Entries tagged "pharmaceutical"
Buyout shops attempted to employ an old strategy to put money to work in the Sepracor deal before a strategic swallowed the pharma.
Why companies developing cancer treatments are particularly attractive right now.
In August, Procter & Gamble wrote another chapter in its history book by selling its prescription drug business for more than $3 billion to Warner Chilcott.
The FTC tries finally to end Generics' pay-for-delay Deals with branded pharma. But will it survive the healthcare reform?
FTC Chairman Jon Leibowitz has urged Congress to pass controversial legislation amending the antitrust laws to prohibit 'reverse payment' or 'pay for delay' patent settlements between branded and generic pharma companies.
Royalty financing techniques with respect to pharmaceutical and biotech assets are becoming broader and more complex.
